

Publisher: Karger
E-ISSN: 2296-5262|31|11|580-582
ISSN: 2296-5270
Source: Oncology Research and Treatment, Vol.31, Iss.11, 2008-10, pp. : 580-582
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content


Wiener Medizinische Wochenschrift, Vol. 160, Iss. 7-8, 2010-04 ,pp. :


The role of the androgen receptor in triple-negative breast cancer
By Shah Payal D Gucalp Ayca Traina Tiffany A
Women's Health, Vol. 9, Iss. 4, 2013-07 ,pp. :


Clinicopathologic and Prognostic Characteristics of Triple-Negative Breast Cancer
Oncology Research and Treatment, Vol. 31, Iss. 11, 2008-10 ,pp. :


Therapeutic targets of triple‐negative breast cancer: a review
BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 17, 2015-09 ,pp. :